Table 2.
Bactericidal activity of antimicrobials alone against the seven Pseudomonas aeruginosa clinical strains.
| Clinical Strain | PNT | AMK | GEN | TOB | IMP | MEM | ATM | CAZ | CIP | LFX | COL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pa29 | B (2–8) | - | - | - | NA | NA | - | NA | - | - | - |
| Pa194 | B (2–8) | NA | NA | B (2–8) | NA | B (8) | - | NA | NA | B (2–24) | - |
| Pa206 | B (2–24) | - | - | - | NA | NA | - | - | NA | B (8–24) | - |
| Pa215 | B (2–4) | B (8) | NA | - | NA | NA | - | NA | NA | NA | B (2–8) |
| Pa223 | NA | NA | - | - | NA | NA | - | NA | NA | NA | - |
| Pa249 | B (8) | - | - | - | NA | NA | B (8–24) | - | NA | B (2–24) | - |
| Pa302 | B (8–24) | - | - | - | NA | - | - | - | - | NA | - |
PNT: pentamidine; AMK: amikacin; GEN: gentamicin; TOB: tobramycin; IMP, imipenem; MEM: meropenem; ATM: aztreonam; CAZ: ceftazidime; CIP: ciprofloxacin; LFX: levofloxacin; COL: Colistin. B: bactericidal; NA: no bactericidal activity; (): time frame in hours of the bactericidal in vitro activity; -: analysis not performed.